Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial - 12/04/19
Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group
Funding sources: Supported by the Office of Research and Development Cooperative Studies Program, US Department of Veterans Affairs. |
|
Conflicts of interest: Dr Weinstock is employed by Brown Dermatology Inc and served as a consultant to AbbVie and Celgene. All other authors have no conflicts of interest to disclose. |
|
Previously presented results as a poster at the Society for Investigative Dermatology 75th annual meeting in Scottsdale, Arizona, in May 2016. |
|
Disclaimer: The opinions expressed in this manuscript are those of the authors, not the Department of Veterans Affairs or the US Government. |
Vol 80 - N° 5
P. 1458-1459 - mai 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?